- Home
- CTXR vs SISI Comparison
CTXR vs SISI Comparison
Compare CTXR & SISI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTXR
- SISI
- Stock Information
- Founded
- CTXR 2007
- SISI 1997
- Country
- CTXR United States
- SISI China
- Employees
- CTXR N/A
- SISI N/A
- Industry
- CTXR Biotechnology: Pharmaceutical Preparations
- SISI Medicinal Chemicals and Botanical Products
- Sector
- CTXR Health Care
- SISI Health Care
- Exchange
- CTXR Nasdaq
- SISI Nasdaq
- Market Cap
- CTXR 14.6M
- SISI 14.9M
- IPO Year
- CTXR N/A
- SISI 2016
- Fundamental
- Price
- CTXR $0.94
- SISI $0.68
- Analyst Decision
- CTXR Strong Buy
- SISI
- Analyst Count
- CTXR 2
- SISI 0
- Target Price
- CTXR $54.50
- SISI N/A
- AVG Volume (30 Days)
- CTXR 142.3K
- SISI 1.1M
- Earning Date
- CTXR 05-23-2025
- SISI 05-27-2025
- Dividend Yield
- CTXR N/A
- SISI N/A
- EPS Growth
- CTXR N/A
- SISI N/A
- EPS
- CTXR N/A
- SISI N/A
- Revenue
- CTXR N/A
- SISI $11,072,553.00
- Revenue This Year
- CTXR N/A
- SISI N/A
- Revenue Next Year
- CTXR N/A
- SISI N/A
- P/E Ratio
- CTXR N/A
- SISI N/A
- Revenue Growth
- CTXR N/A
- SISI 145.88
- 52 Week Low
- CTXR $0.68
- SISI $0.39
- 52 Week High
- CTXR $26.25
- SISI $117.65
- Technical
- Relative Strength Index (RSI)
- CTXR 51.36
- SISI 43.19
- Support Level
- CTXR $0.65
- SISI $0.56
- Resistance Level
- CTXR $0.82
- SISI $0.79
- Average True Range (ATR)
- CTXR 0.09
- SISI 0.13
- MACD
- CTXR 0.04
- SISI -0.01
- Stochastic Oscillator
- CTXR 85.69
- SISI 20.14
About CTXR Citius Pharmaceuticals Inc.
Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.
About SISI Shineco Inc.
Shineco Inc aims to care for a healthy life and improve the quality of life by providing safe, efficient, and high-quality health products and services to society. The company has researched and developed various vitro diagnostic reagents and related medical devices to date, and it also produces and sells healthy and nutritious food.